8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2008 / Randomized, placebo-controlled, double-blinded study
Healthy adults aged 18-84 received placebo, 1000 IU vitamin D3, 1000 IU vitamin D2, or 500 IU D2 plus 500 IU D3 daily for 11 weeks at the end of winter. Circulating 25-hydroxyvitamin D increased to the same extent in groups receiving 1000 IU D2 (from 16.9+/-10.5 to 26.8+/-9.6 ng/ml), 1000 IU D3 (from 19.6+/-11.1 to 28.9+/-11.0 ng/ml), or the combination (from 20.2+/-10.4 to 28.4+/-7.7 ng/ml). Levels of 25-hydroxyvitamin D3 did not change in the 1000 IU D2 group, and neither 1000 IU dose raised levels above 30 ng/ml in vitamin D-deficient subjects.
Holick MF, Biancuzzo RM, Chen TC, et al. J Clin Endocrinol Metab, 2008. PMID 18089691
2008 / Randomized crossover imaging trial
Researchers assessed taste pleasantness across a concentration gradient and measured brain responses via functional MRI during administration of 10% sucrose and matched sucralose in 12 healthy women. Both sweeteners activated functionally connected primary taste pathways, and taste pleasantness predicted left insula response. However, sucrose elicited a stronger brain response than sucralose in the anterior insula, frontal operculum, striatum, and anterior cingulate. Additionally, only sucrose stimulation engaged dopaminergic midbrain areas in relation to behavioral pleasantness.
Frank GK, Oberndorfer TA, Simmons AN, et al. Neuroimage, 2008. PMID 18096409
2008 / Randomized controlled trial
In a five-year randomized controlled trial of 1,471 postmenopausal women, adjudicated myocardial infarction occurred in 21 women receiving calcium versus 10 receiving placebo (relative risk 2.12, 95% CI 1.01 to 4.47). The composite endpoint of myocardial infarction, stroke, or sudden death occurred in 51 calcium recipients versus 35 placebo recipients (relative risk 1.47, 95% CI 0.97 to 2.23). Adding hospital data yielded a composite rate ratio of 1.43 (95% CI 1.01 to 2.04).
Bolland MJ, Barber PA, Doughty RN, et al. BMJ, 2008. PMID 18198394
2008 / Randomized controlled trial
Ninety-four healthy Japanese women were randomized to either consume high amounts of six selected vegetables (target 350 g/day) or avoid those vegetables for 65 days. At the end of the intervention, daily mean melatonin intake from the six vegetables was 1288.0 ng in the intervention group and 5.3 ng in the control group. Mean urinary 6-sulfatoxymelatonin changed from 48.1 to 49.6 ng/mg creatinine in the intervention group and from 55.5 to 50.8 ng/mg creatinine in the control group. The change across the intervention period differed significantly between the two groups (P = 0.03).
Oba S, Nakamura K, Sahashi Y, et al. J Pineal Res, 2008. PMID 18205730
2008 / Randomized controlled trial
Ninety-three early-stage prostate cancer patients were randomized to usual care or a very-low-fat vegan diet with soy supplementation and lifestyle changes for 1 year. The intervention group significantly increased protective factors, such as fiber (31 to 59 g/day) and lycopene (8,693 to 34,464 mcg/day). Pathogenic factors decreased, including saturated fat (20 to 5 g/day) and cholesterol (200 to 10 mg/day).
Dewell A, Weidner G, Sumner MD, et al. J Am Diet Assoc, 2008. PMID 18237581
2008 / Prospective interventional study with parallel control group
Eighteen healthy participants aimed for a 5-15% body weight increase by eating at least two fast-food meals daily to double calorie intake while adopting a sedentary lifestyle for 4 weeks, compared with matched controls. Intervention subjects increased weight from 67.6 (9.1) kg to 74.0 (11) kg (p<0.001), and serum ALT increased from 22.1 (11.4) U/l to a mean maximum of 97 (103) U/l (range 19.4-447 U/l). Eleven of 18 subjects had persistently elevated ALT above reference limits. Hepatic triglyceride content rose from 1.1 (1.9)% to 2.8 (4.8)%, but was not related to ALT increases; ALT was unchanged in controls.
Kechagias S, Ernersson A, Dahlqvist O, et al. Gut, 2008. PMID 18276725
2008 / Randomized controlled trial (post-hoc cohort analysis)
Data from the ATBC Study was analyzed to determine if supplementation with vitamin E (50 mg/d) or beta-carotene (20 mg/d) affected tuberculosis risk over a median 6.1-year intervention. Overall, neither vitamin E (RR = 1.18; 95% CI 0.87, 1.59) nor beta-carotene (RR = 1.07; 95% CI 0.80, 1.45) significantly affected tuberculosis incidence. However, among participants consuming 90 mg/d or more of dietary vitamin C (n = 13,502), vitamin E supplementation increased tuberculosis risk by 72% (95% CI 4, 185)%, an effect restricted to heavy smokers. Among those not receiving vitamin E, dietary vitamin C was negatively associated with tuberculosis risk, with a 60% (95% CI 16, 81)% lower risk in the highest versus lowest quartile.
Hemilä H, Kaprio J Br J Nutr, 2008. PMID 18279551
2008 / Pre-post intervention trial with a cross-sectional comparison group
Researchers tested whether serum from men following a low-fat, high-fiber diet and regular exercise affected primary prostate epithelial cells in culture. Serum was collected from 8 overweight men before and after a 2-week Pritikin residential intervention, and from 7 long-term followers. At 96 hours, cell growth was significantly reduced using serum from the 2-week group (by 13%) and the long-term group (by 14%) compared to pre-intervention serum, with no significant difference in apoptosis among groups. Fasting insulin was reduced by 30% in the 2-week group and by 52% in the long-term group compared to baseline, while testosterone was unchanged in the 2-week group.
Barnard RJ, Kobayashi N, Aronson WJ Prostate Cancer Prostatic Dis, 2008. PMID 18283296
2008 / Randomized crossover trial
In 32 asthmatic adults, a 10-day low-antioxidant diet reduced plasma carotenoids, worsened asthma control scores, and impaired lung function. Subsequent randomized crossover treatment with tomato extract or tomato juice providing 45 mg lycopene daily for 7 days lowered airway neutrophil influx. Sputum neutrophil elastase activity was also reduced following tomato extract supplementation.
Wood LG, Garg ML, Powell H, et al. Free Radic Res, 2008. PMID 18324527
2008 / Randomized controlled trial
Fifteen healthy subjects consumed cereal-based bread evening meals varying in GI and indigestible carbohydrates to assess effects on a subsequent standardized breakfast. Evening meals with barley kernel-based bread or white wheat bread (WWB) enriched with barley fiber and resistant starch improved glucose tolerance at breakfast compared with unsupplemented WWB (P < 0.05). Following barley-kernel bread, IL-6 was lower (P < 0.01) and adiponectin was higher (P < 0.05) compared with WWB. Glucose response at breakfast was inversely correlated with colonic fermentation (r = -0.25; P < 0.05) and GLP-1 (r = -0.26; P < 0.05), while breath hydrogen correlated positively with satiety (r = 0.27; P < 0.01) and inversely with gastric emptying rate (r = -0.23; P < 0.05).
Nilsson AC, Ostman EM, Holst JJ, et al. J Nutr, 2008. PMID 18356328
2008 / Randomized controlled trial
Circulating 25-hydroxyvitamin D was measured in 184 patients with diffuse musculoskeletal pain and 104 osteoarthritis controls, showing no significant difference between groups (29.2 +/- 13.0 vs 28.8 +/- 10.5 ng/mL, P = 0.78). Fifty patients with levels of 20 ng/mL or lower were randomized to ergocalciferol (50,000 IU weekly) or placebo for 3 months. Vitamin D treatment did not significantly improve pain compared to baseline (P = 0.73) or compared to placebo at 3 months (P = 0.12).
Warner AE, Arnspiger SA J Clin Rheumatol, 2008. PMID 18431091
2008 / Randomized controlled trial
In a randomized trial, 58 men at risk of or with low-grade prostate cancer consumed 40 g daily of isoflavone-rich soy protein, alcohol-washed soy protein, or milk protein for 6 months. Serum PSA and prostate tissue biomarkers did not change with isoflavone-rich soy protein, whereas Bax expression decreased with alcohol-washed soy. A significantly lower rate of prostate cancer was detected in the soy groups compared to the milk group (P = 0.01).
Hamilton-Reeves JM, Rebello SA, Thomas W, et al. Nutr Cancer, 2008. PMID 18444130
2008 / Randomized controlled trial
In a randomized trial of 220 adults with asthma following a low-sodium diet, participants received either 80 mmol/day sodium supplements or placebo for six weeks. Among 199 protocol completers, daily urinary sodium excretion dropped by 20 mmol (SD 64) on placebo and rose by 28 mmol (SD 74) on supplements. Bronchial reactivity showed no significant difference between groups, with a mean difference of -0.03 doubling doses of methacholine (95% CI, -0.60 to 0.53).
Pogson ZE, Antoniak MD, Pacey SJ, et al. Am J Respir Crit Care Med, 2008. PMID 18451321
2008 / Randomized, double-blind, placebo-controlled trial
Thirty-two hypokalemic women with active rheumatoid arthritis were randomized to receive their usual medication plus either placebo or 6,000 mg potassium chloride dissolved in grape juice daily for 28 consecutive days. At day 28, 43.75% (7/16) of patients in the potassium group met the criteria for a 33% reduction in pain intensity compared with 6.25% (1/16) in the placebo group (P < .02). Additionally, 31.25% (5/16) of patients receiving potassium achieved a EULAR moderate response compared to 6.25% (1/16) in the placebo group (P < .05). Elevated serum cortisol and potassium values in the treatment group correlated negatively with pain intensity.
Rastmanesh R, Abargouei AS, Shadman Z, et al. J Pain, 2008. PMID 18468955
2008 / Crossover randomized intervention
In a crossover study, 33 healthy adults consumed high- and low-total antioxidant capacity (TAC) diets for 2 weeks each. Dietary TAC, alpha-tocopherol, and ascorbic acid were significantly higher during the high-TAC diet (P < 0.001), and plasma alpha-tocopherol rose significantly more than during the low-TAC diet (P < 0.02) without changes in oxidative stress markers, though plasma malondialdehyde unexpectedly fell during the low-TAC diet. Plasma hs-CRP, ALT, GGT, and alkaline phosphatase decreased significantly during the high-TAC versus low-TAC diet (pre-post changes: hs-CRP -0.72 +/- 0.37 vs 1.05 +/- 0.60 mg/L; ALT -1.73 +/- 1.02 vs 2.33 +/- 2.58 U/L; GGT -2.12 +/- 1.45 vs 5.15 +/- 2.98 U/L; and ALP 1.36 +/- 1.34 vs 5.06 +/- 2.00 U/L).
Valtueña S, Pellegrini N, Franzini L, et al. Am J Clin Nutr, 2008. PMID 18469252
2008 / Randomized controlled trial
A randomized controlled trial in 56 healthy Caucasian women over age 50 tested sunbeds with 0.5% UVB (n = 20) or 1.4% UVB (n = 15) against an untreated control group (n = 21). Average serum 25(OH)D increased by day 9 by 12 nmol/L (SD 11, P = 0.0002) in the 0.5% group and 27 nmol/L (SD 9, P < 0.0001) in the 1.4% group. However, 37% to 64% of sessions produced side effects such as erythema.
Thieden E, Jørgensen HL, Jørgensen NR, et al. Photochem Photobiol, 2008. PMID 18513233
2008 / Phase I non-randomized clinical trial
In a phase I dose-finding study, patients with advanced cancer received infusions of ascorbic acid ranging from 0.4 to 1.5 g/kg three times weekly. Toxicity and adverse events were minimal across all dose groups. However, no participant showed an objective anticancer response.
Hoffer LJ, Levine M, Assouline S, et al. Ann Oncol, 2008. PMID 18544557
2008 / Intervention trial
Researchers evaluated antioxidant contents of cranberry products and conducted an intervention where 10 normal individuals consumed 240 mL of high fructose corn syrup (HFCS) and ascorbate, either with cranberry juice (CJ) antioxidants or without (control). Control HFCS caused a slight decrease in plasma antioxidant capacity at all time points over 7 hours, whereas CJ produced an increase in plasma antioxidant capacity that was significantly greater than control at all time points. Postprandial triglycerides from fructose were mainly responsible for the oxidative stress and significantly correlated with antioxidant capacity reduction.
Vinson JA, Bose P, Proch J, et al. J Agric Food Chem, 2008. PMID 18558697
2008 / Crossover trial
In a balanced order, nine healthy normal-weight men spent three nights in a sleep laboratory separated by at least 2 weeks: 7 hours of sleep, 4.5 hours of sleep, or total sleep deprivation. Subjects reported significantly stronger feelings of hunger after total sleep deprivation than after 7 hours of sleep (3.9 +/- 0.7 vs. 1.7 +/- 0.3; P = 0.020) or 4.5 hours of sleep (2.2 +/- 0.5; P = 0.041). Plasma ghrelin levels were 22 +/- 10% higher after total sleep deprivation than after 7 hours of sleep (0.85 +/- 0.06 vs. 0.72 +/- 0.04 ng mL(-1); P = 0.048), with intermediate levels after 4.5 hours of sleep (0.77 +/- 0.04 ng mL(-1)). Serum leptin levels did not differ between the conditions.
Schmid SM, Hallschmid M, Jauch-Chara K, et al. J Sleep Res, 2008. PMID 18564298
2008 / Acute pharmacokinetic study and crossover trial
In part one, 7 volunteers ingested two 1.66 g taurine doses. Plasma taurine rose from 64+/-4 microM to peaks of 778+/-139 microM at 10 AM and 973+/-181 microM at 1 PM. In part two, 8 men cycled for 2 hours after 7 days of placebo (6 g glucose/day) and after 7 days of taurine (5 g/day). Seven days of taurine had no effect on muscle taurine content (mmol/kg dry muscle) at rest (placebo: 44+/-15 vs. taurine: 42+/-15) or after exercise (placebo: 43+/-12 vs. taurine: 43+/-11). There was no difference in muscle glycogen or carbohydrate and fat oxidation between conditions, though interaction effects were noted for muscle valine, isoleucine, leucine, cystine, glutamate, alanine, and arginine following exercise.
Galloway SD, Talanian JL, Shoveller AK, et al. J Appl Physiol (1985), 2008. PMID 18583380
2008 / Randomized crossover trial
In a randomized trial, 30 healthy women consumed ad libitum meals under slow and quick eating conditions across two visits. Slow ingestion decreased energy intake compared to rapid ingestion (579.0 +/- 154.7 vs. 645.7 +/- 155.9 kcal; P < 0.05) and increased water intake (409.6 +/- 205.8 vs. 289.9 +/- 155.1 g; P < 0.05). Despite consuming fewer calories, participants reported significantly higher post-meal satiety during the slow session.
Andrade AM, Greene GW, Melanson KJ J Am Diet Assoc, 2008. PMID 18589027
2008 / Randomized controlled trial
A 2-week randomized parallel-group trial compared 600 mg daily of docosahexaenoic acid from algal-oil capsules or cooked salmon in 32 healthy adults. Docosahexaenoic acid concentrations increased by approximately 80% in plasma phospholipids and by about 25% in erythrocytes in both arms. Changes in biomarker levels did not differ between interventions, indicating bioequivalence for delivering this fatty acid to plasma and red blood cells.
Arterburn LM, Oken HA, Bailey Hall E, et al. J Am Diet Assoc, 2008. PMID 18589030
2008 / Multicenter randomized, controlled, single-blinded clinical trial
A multicenter trial randomly assigned 1,277 peripheral arterial disease patients to iron reduction by phlebotomy (n = 636) or control (n = 641), followed for an average of 4.5 years. Risk of new visceral malignancy was lower in the iron reduction group compared to control (38 vs 60; HR = 0.65, 95% CI = 0.43 to 0.97; P = .036). Among patients who developed new cancers, those in the iron reduction group had lower cancer-specific mortality (HR = 0.39, 95% CI = 0.21 to 0.72; P = .003) and lower all-cause mortality (HR = 0.49, 95% CI = 0.29 to 0.83; P = .009).
Zacharski LR, Chow BK, Howes PS, et al. J Natl Cancer Inst, 2008. PMID 18612130
2008 / Interventional and observational human study
Researchers investigated the physiological regulation of circulating FGF21 in humans. Serum FGF21 varied 250-fold among 76 healthy individuals and did not relate to age, gender, BMI, serum lipids, or plasma glucose, with no diurnal variation. Ketosis from a 2-day fast or ketogenic diet did not alter FGF21 levels, but a 74% increase occurred after 7 days of fasting. Hypertriglyceridemic nondiabetic patients had 2-fold higher FGF21 levels, which increased an additional 28% during fenofibrate treatment.
Gälman C, Lundåsen T, Kharitonenkov A, et al. Cell Metab, 2008. PMID 18680716